デフォルト表紙
市場調査レポート
商品コード
1623926

院内肺炎予防の世界市場:業界分析、規模、シェア、成長、動向、予測(2025年~2032年)

Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032


出版日
ページ情報
英文 229 Pages
納期
2~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
院内肺炎予防の世界市場:業界分析、規模、シェア、成長、動向、予測(2025年~2032年)
出版日: 2025年01月02日
発行: Persistence Market Research
ページ情報: 英文 229 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の院内肺炎予防の市場規模は、2025年に218億米ドルになるとみられ、2025年~2032年の予測期間に5.6%のCAGRで拡大し、2032年には320億米ドルに達すると予測されています。

院内肺炎予防市場には、ヘルスケア環境で発症する肺炎の発生率を低減することを目的とした様々な製品、技術、サービスが含まれます。これらのソリューションには、高度な医療機器、効果的な感染制御プロトコル、革新的な医薬品治療、衛生管理の強化などが含まれます。同市場は、病院、長期介護施設、外来手術センターなど多様な利害関係者にサービスを提供しています。成長の原動力は、患者の安全性への関心の高まり、医療費の増加、感染予防技術の進歩です。

世界の院内肺炎予防市場を牽引している主な要因はいくつかあります。院内感染(HAI)の世界の流行増加は、効果的な予防戦略の必要性を強調しています。非侵襲的人工呼吸器や抗菌コート医療機器などの診断ツールや予防ケアソリューションの革新が市場拡大に寄与しています。感染管理のコンプライアンスを重視する規制の枠組みは、市場の成長をさらに促進します。さらに、ヘルスケア専門家や組織における患者の安全に対する意識の高まりが、感染予防対策への投資を促進しています。

同市場は、個別化されたヘルスケアソリューションに対する需要の高まりと、感染モニタリングのためのデジタルヘルス技術の採用増加により、大きな機会をもたらしています。診断ツールに人工知能(AI)と機械学習(ML)を統合することで、院内肺炎の早期発見と予防が強化されます。生分解性消毒剤など、費用対効果が高く環境に優しい感染制御ソリューションの開発は、ヘルスケアにおける持続可能性への注目の高まりに対応しています。高度な感染防止対策を実施するためのヘルスケア機関とテクノロジープロバイダーとのパートナーシップは、市場の可能性をさらに拡大します。

当レポートでは、世界の院内肺炎予防市場について調査し、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 院内肺炎予防市場機会分析

第4章 市場背景

  • 市場力学
  • 院内肺炎- 病因評価
  • 院内肺炎の病因
  • バリューチェーン分析
  • 親市場分析
  • 需給分析(ギャップ分析)
  • 地域別医療費分析

第5章 世界経済の見通し

第6章 北米の院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)

第7章 ラテンアメリカの院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)

第8章 欧州の院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)

第9章 中国を除くアジア太平洋の院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)

第10章 中国の院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)

第11章 中東・アフリカの院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)

第12章 予測の前提条件

第13章 競合分析

  • 企業シェア分析(2024年)
  • 競合ダッシュボード
  • 企業の詳細
    • Sage Products LLC (Stryker Corporation)
    • Intersurgical Ltd.
    • Medline Industries, Inc.
    • Halyard Health, Inc.

第14章 世界の院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)、地域別

  • 過去の市場規模(10億米ドル)動向分析、地域別、2020年~2024年
  • 市場規模(10億米ドル)予測、地域別、2025年~2032年
  • 市場の魅力分析、地域別

第15章 世界の院内肺炎予防分析(2020年~2024年)および予測(2025年~2032年)、製品タイプ別

第16章 世界の院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)、エンドユーザー別

第17章 世界の院内肺炎予防市場分析(2020年~2024年)および予測(2025年~2032年)

第18章 使用される仮定と頭字語

第19章 調査手法

目次
Product Code: PMRREP22768

Persistence Market Research has recently published an extensive report on the global Hospital-Acquired Pneumonia Prevention Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Hospital-Acquired Pneumonia Prevention Market Size (2025E): USD 21.8 Bn
  • Projected Market Value (2032F): USD 32.0 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.6%

Hospital-Acquired Pneumonia Prevention Market - Report Scope:

The Hospital-Acquired Pneumonia Prevention Market encompasses a variety of products, technologies, and services aimed at reducing the incidence of pneumonia acquired in healthcare settings. These solutions include advanced medical devices, effective infection control protocols, innovative pharmaceutical treatments, and enhanced sanitation practices. The market serves diverse stakeholders, including hospitals, long-term care facilities, and ambulatory surgical centers. Growth is driven by the increasing focus on patient safety, rising healthcare expenditures, and technological advancements in infection prevention.

Market Growth Drivers:

Several key factors are driving the global Hospital-Acquired Pneumonia Prevention Market. The increasing prevalence of hospital-acquired infections (HAIs) globally underscores the need for effective prevention strategies. Innovations in diagnostic tools and preventive care solutions, such as non-invasive ventilators and antimicrobial-coated medical devices, contribute to market expansion. Regulatory frameworks emphasizing infection control compliance further propel market growth. Additionally, heightened awareness of patient safety among healthcare professionals and organizations has driven investments in infection prevention measures.

Market Restraints:

Despite promising growth prospects, the Hospital-Acquired Pneumonia Prevention Market faces challenges related to the high costs associated with advanced preventive solutions. Budget constraints in low-income healthcare settings limit the adoption of cutting-edge technologies. Additionally, the complexity of implementing comprehensive infection prevention protocols in under-resourced facilities poses challenges. The potential for the development of antibiotic-resistant pathogens adds another layer of complexity, requiring continuous innovation and investment in research and development to overcome these hurdles.

Market Opportunities:

The market presents significant opportunities driven by the growing demand for personalized healthcare solutions and the rising adoption of digital health technologies for infection monitoring. The integration of artificial intelligence (AI) and machine learning (ML) in diagnostic tools enhances early detection and prevention of hospital-acquired pneumonia. The development of cost-effective and eco-friendly infection control solutions, such as biodegradable disinfectants, caters to the growing focus on sustainability in healthcare. Partnerships between healthcare organizations and technology providers to implement advanced infection prevention measures further expand market potential.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Hospital-Acquired Pneumonia Prevention Market globally?
  • Which types of products and services are leading the adoption in various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the Hospital-Acquired Pneumonia Prevention Market?
  • Who are the key players in the Hospital-Acquired Pneumonia Prevention Market
  • What strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Hospital-Acquired Pneumonia Prevention Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Hospital-Acquired Pneumonia Prevention Market, including 3M, Becton, Dickinson and Company, and Medtronic, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced preventive care solutions and explore new applications for existing products. Collaborations with healthcare providers, government bodies, and research organizations facilitate the implementation of effective infection prevention strategies. Emphasis on consumer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Hospital-Acquired Pneumonia Prevention Market landscape.

Key Companies Profiled:

  • Sage Products LLC (Stryker Corporation)
  • Intersurgical Ltd.
  • Medline Industries, Inc.
  • Halyard Health, Inc.
  • Others.

Hospital-Acquired Pneumonia Prevention Market Industry Segmentation:

Segmentation by Product Type

  • Oral Care Kit
  • Toothbrush
  • Swab
  • Moisturizer
  • Mouth Wash
  • Suction Tools

Segmentation by End-user

  • Hospitals
  • Rehabilitation Centers
  • Home Care Settings

Segmentation by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding China (APEC)
  • China
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Hospital-Acquired Pneumonia Prevention Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. Market Dynamics
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Global Trends
  • 4.2. Hospital-Acquired Pneumonia - Etiology Assessment
  • 4.3. Hospital-Acquired Pneumonia Pathogenesis
  • 4.4. Value Chain Analysis
  • 4.5. Parent Market Analysis
  • 4.6. Supply Demand Analysis (Gap Analysis)
  • 4.7. Regional Cost of Care Analysis

5. Global Economic Outlook

  • 5.1. Gross Domestic Therapy by Region & Country, 2025 - 2032
  • 5.2. Global Healthcare Outlook

6. North America Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 6.1. Introduction
  • 6.2. Key Market Trends
  • 6.3. Historical Market Size (US$ Bn) Analysis By Country, 2020 - 2024
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 6.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
    • 6.5.1. Oral Care Kits
    • 6.5.2. Toothbrush
    • 6.5.3. Swab
    • 6.5.4. Moisturizer
    • 6.5.5. Mouthwash
    • 6.5.6. Suction Tools
  • 6.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
  • 6.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 6.7.1. Hospitals
    • 6.7.2. Rehabilitation Centers
    • 6.7.3. Home Care Settings
  • 6.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 6.9. Market Attractiveness Analysis
    • 6.9.1. By Country
    • 6.9.2. By Product Type
    • 6.9.3. By End User
  • 6.10.Drivers and Restraints - Impact Analysis

7. Latin America Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 7.1. Introduction
  • 7.2. Key Market Trends
  • 7.3. Historical Market Size (US$ Bn) Trends Analysis By Country, 2020 - 2024
    • 7.3.1. Argentina
    • 7.3.2. Brazil
    • 7.3.3. Mexico
    • 7.3.4. Rest of Latin America
  • 7.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 7.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
    • 7.5.1. Oral Care Kits
    • 7.5.2. Toothbrush
    • 7.5.3. Swab
    • 7.5.4. Moisturizer
    • 7.5.5. Mouthwash
    • 7.5.6. Suction Tools
  • 7.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
  • 7.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 7.7.1. Hospitals
    • 7.7.2. Rehabilitation Centers
    • 7.7.3. Home Care Settings
  • 7.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 7.9. Market Attractiveness Analysis
    • 7.9.1. By Country
    • 7.9.2. By Product Type
    • 7.9.3. By End User
  • 7.10.Drivers and Restraints - Impact Analysis

8. Europe Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 8.1. Introduction
  • 8.2. Key Market Trends
  • 8.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
    • 8.3.1. Germany
    • 8.3.2. U.K.
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Poland
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 8.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
    • 8.5.1. Oral Care Kits
    • 8.5.2. Toothbrush
    • 8.5.3. Swab
    • 8.5.4. Moisturizer
    • 8.5.5. Mouthwash
    • 8.5.6. Suction Tools
  • 8.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
  • 8.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 8.7.1. Hospitals
    • 8.7.2. Rehabilitation Centers
    • 8.7.3. Home Care Settings
  • 8.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 8.9. Market Attractiveness Analysis
    • 8.9.1. By Country
    • 8.9.2. By Product Type
    • 8.9.3. By End User
  • 8.10. Drivers and Restraints - Impact Analysis

9. Asia Pacific Excluding China Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 9.1. Introduction
  • 9.2. Key Market Trends
  • 9.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
    • 9.3.1. Japan
    • 9.3.2. India
    • 9.3.3. Australia and New Zealand
    • 9.3.4. Rest of Asia Pacific
  • 9.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 9.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
    • 9.5.1. Oral Care Kits
    • 9.5.2. Toothbrush
    • 9.5.3. Swab
    • 9.5.4. Moisturizer
    • 9.5.5. Mouthwash
    • 9.5.6. Suction Tools
  • 9.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
  • 9.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 9.7.1. Hospitals
    • 9.7.2. Rehabilitation Centers
    • 9.7.3. Home Care Settings
  • 9.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 9.9. Market Attractiveness Analysis
    • 9.9.1. By Country
    • 9.9.2. By Product Type
    • 9.9.3. By End User
  • 9.10. Drivers and Restraints - Impact Analysis

10. China Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 10.1. Introduction
  • 10.2. Key Market Trends
  • 10.3. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
    • 10.3.1. Oral Care Kits
    • 10.3.2. Toothbrush
    • 10.3.3. Swab
    • 10.3.4. Moisturizer
    • 10.3.5. Mouthwash
    • 10.3.6. Suction Tools
  • 10.4. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
  • 10.5. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 10.5.1. Hospitals
    • 10.5.2. Rehabilitation Centers
    • 10.5.3. Home Care Settings
  • 10.6. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Country
    • 10.7.2. By Product Type
    • 10.7.3. By End User
  • 10.8. Drivers and Restraints - Impact Analysis

11. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 11.1. Introduction
  • 11.2. Key Market Trends
  • 11.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
    • 11.3.1. GCC Countries
    • 11.3.2. South Africa
    • 11.3.3. Rest of MEA
  • 11.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
  • 11.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
    • 11.5.1. Oral Care Kits
    • 11.5.2. Toothbrush
    • 11.5.3. Swab
    • 11.5.4. Moisturizer
    • 11.5.5. Mouthwash
    • 11.5.6. Suction Tools
  • 11.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
  • 11.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 11.7.1. Hospitals
    • 11.7.2. Rehabilitation Centers
    • 11.7.3. Home Care Settings
  • 11.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 11.9. Market Attractiveness Analysis
    • 11.9.1. By Country
    • 11.9.2. By Product Type
    • 11.9.3. By End User
  • 11.10. Drivers and Restraints - Impact Analysis

12. Forecast Assumptions

13. Competition Analysis

  • 13.1. Company Share Analysis (2024)
  • 13.2. Competition Dashboard
  • 13.3. Company Deep Dive
    • 13.3.1. Sage Products LLC (Stryker Corporation)
      • 13.3.1.1. Overview
      • 13.3.1.2. Product Portfolio
      • 13.3.1.3. Sales Footprint
      • 13.3.1.4. Strategy
        • 13.3.1.4.1. Marketing Strategy
        • 13.3.1.4.2. Therapy Strategy
        • 13.3.1.4.3. Channel Strategy
    • 13.3.2. Intersurgical Ltd.
      • 13.3.2.1. Overview
      • 13.3.2.2. Product Portfolio
      • 13.3.2.3. Sales Footprint
      • 13.3.2.4. Strategy
        • 13.3.2.4.1. Marketing Strategy
        • 13.3.2.4.2. Therapy Strategy
        • 13.3.2.4.3. Channel Strategy
    • 13.3.3. Medline Industries, Inc.
      • 13.3.3.1. Overview
      • 13.3.3.2. Product Portfolio
      • 13.3.3.3. Sales Footprint
      • 13.3.3.4. Strategy
        • 13.3.3.4.1. Marketing Strategy
        • 13.3.3.4.2. Therapy Strategy
        • 13.3.3.4.3. Channel Strategy
    • 13.3.4. Halyard Health, Inc.
      • 13.3.4.1. Overview
      • 13.3.4.2. Product Portfolio
      • 13.3.4.3. Sales Footprint
      • 13.3.4.4. Strategy
        • 13.3.4.4.1. Marketing Strategy
        • 13.3.4.4.2. Therapy Strategy
        • 13.3.4.4.3. Channel Strategy

14. Global Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Region

  • 14.1. Introduction/Key Findings
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis By Region, 2020 - 2024
  • 14.3. Market Size (US$ Bn) Forecast By Region, 2025 - 2032
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. Asia Pacific Excluding China
    • 14.3.5. China
    • 14.3.6. Middle East & Africa
  • 14.4. Market Attractiveness Analysis By Region

15. Global Hospital-Acquired Pneumonia Prevention Analysis 2020 - 2024 and Forecast 2025 - 2032, By Product Type

  • 15.1. Introduction/Key Findings
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
    • 15.2.1. Oral Care Kits
    • 15.2.2. Toothbrush
    • 15.2.3. Swab
    • 15.2.4. Moisturizer
    • 15.2.5. Mouthwash
    • 15.2.6. Suction Tools
  • 15.3. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
  • 15.4. Market Attractiveness Analysis By Product Type

16. Global Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By End User

  • 16.1. Introduction/Key Findings
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
    • 16.2.1. Hospitals
    • 16.2.2. Rehabilitation Centers
    • 16.2.3. Home Care Settings
  • 16.3. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
  • 16.4. Market Attractiveness Analysis By End User

17. Global Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

  • 17.1. Market Value Share Analysis By All Segment
  • 17.2. Y-o-Y Growth Analysis By All Segment
  • 17.3. Absolute $ Opportunity

18. Assumptions and Acronyms Used

19. Research Methodology